CRNX Disposition Disclosure
Struthers Richard Scott · SEC Form 4 · Filed Sep 1, 2026
Disposition
Calculated transaction value
$18.8M
Struthers Richard Scott President & CEO
CRNX
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
CRNX daily price context
Close on/before transaction
$84.95
Sep 1, 2026
Close before public filing
$84.95
Aug 31, 2026
Return since public filing
0.0%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 287,700 shares @ $65.36
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001628280-26-059882
Filing cohort
Transactions in this filing
Showing 15 of 20
Trades
20
Issuers
1
Estimated value
$228.91M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $11.63M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $15.07M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $21.08M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $85K |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $9.01M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $9.35M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $8.5M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $9.44M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $9.44M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $9.44M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $9.44M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $6.8M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $15.02M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $10.3M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $12.2M |